A comparative study of clinicopathological significance, FGFBP1, and WISP-2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladder

International Journal of Clinical Oncology

Volumn 19, Issue 2, 2014, Pages 325-335

  Yang, Zhulin ^a   Yang, Zhi ^a   Zou, Qiong ^b   Yuan, Yuan ^b   Li, Jinghe ^c   Li, Daiqiang ^a   Liang, Lufeng ^d   Zeng, Guixiang ^e   Chen, Senlin ^f  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d Hunan Provincial Second People s Hospital   (China)

^e Loudi Central Hospital   (China)

^f HUNAN CANCER HOSPITAL   (China)

Author keywords

Adenocarcinoma; Adenosquamous carcinoma; FGFBP1; Gallbladder cancer; Metastasis; Prognosis; Squamous cell carcinoma; WISP 2

Indexed keywords

FIBROBLAST GROWTH FACTOR BINDING PROTEIN 1; PROTEIN; PROTEIN WISP 2; UNCLASSIFIED DRUG; CARRIER PROTEIN; CCN PROTEIN; FGFBP1 PROTEIN, HUMAN; REPRESSOR PROTEIN; SIGNAL PEPTIDE; WISP2 PROTEIN, HUMAN;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGE DISTRIBUTION; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CORRELATION ANALYSIS; FEMALE; GALLBLADDER CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; TUMOR INVASION; TUMOR VOLUME; AGED; CHEMISTRY; GALLBLADDER TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CCN INTERCELLULAR SIGNALING PROTEINS; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; REPRESSOR PROTEINS;

EID: 84899910347     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-013-0550-9     Document Type: Article

References (24)

1. Hsing AW, Gao WT, Han TQ et al (2007) Gallstones and the risk of biliary tract cancer: a population-based study in China. Br J Cancer 97:1577-1582 (Pubitemid 350175843)
2. Ootani T, Shirai Y, Tsukada K et al (1992) Relationship between gallbladder carcinoma and the segmental type of adenomyomatosis of the gallbladder. Cancer 69:2647-2652
3. Jayaraman S, Jarnagin WR (2010) Management of gallbladder cancer. Gastroenterol Clin North Am 39:331-342
4. Roa JC, Tapia O, Cakir A et al (2011) Squamous cell and adenosquamous carcinomas of the gallbladder: clinicopathological analysis of 34 cases identified in 606 carcinomas. Mod Pathol 24:1069-1078
5. Reid KM, Ramos-De la Medina A, Donohue JH (2007) Diagnosis and surgical management of gallbladder cancer: a review. J Gastrointest Surg 11:671-681
6. de Aretxabala X, Roa I, Burgos L et al (2006) Gallbladder cancer: an analysis of a series of 139 patients with restricted to the subserosal layer. J Gastrointest Surg 10:186-192 (Pubitemid 43187179)
7. Park SB, Kim YH, Rho HL et al (2012) Primary carcinosarcoma of the gallbladder. J Korean Surg Soc 82:54-58
8. Maurya SK, Tewari M, Mishra RR et al (2012) Genetic aberrations in gallbladder cancer. Surg Oncol 21:37-43
9. Wesche J, Haglund K, Haugsten EM (2011) Fibroblast growth factors and their receptors in cancer. Biochem J 437:199-213
10. Abuharbeid S, Czubayko F, Aigner A (2006) The fibroblast growth factor-binding protein FGF-BP. Int J Biochem Cell Biol 38:1463-1468 (Pubitemid 43729304)
11. Cronauer MV, Schulz WA, Seifert HH et al (2003) Fibroblast growth factors and their receptors in urological cancers: basic research and clinical implications. Eur Urol 43:309-319 (Pubitemid 36314245)
12. Begum S, Zhang Y, Shintani T et al (2007) Immunohistochemical expression of heparin-binding protein 17/fibroblast growth factor-binding protein-1 (HBp17/FGFBP-1) as an angiogenic factor in head and neck tumorigenesis. Oncol Rep 17:591-596
13. Czubayko F, Smith RV, Chung HC et al (1994) Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors. J Biol Chem 269:28243-28248 (Pubitemid 24354563)
14. Aigner A, Renneberg H, Bojunga J et al (2002) Ribozyme-targeting of a secreted FGF-binding protein (FGF-BP) inhibits proliferation of prostate cancer cells in vitro and in vivo. Oncogene 21:5733-5742 (Pubitemid 35333006)
15. Katoh M, Katoh M (2006) Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades. Cancer Biol Ther 5:1059-1064 (Pubitemid 44772212)
16. Katoh M (2011) Network of WNT and other regulatory signaling cascades in pluripotent stem cells and cancer stem cells. Curr Pharm Biotechnol 12:160-170
17. Brigstock DR (2003) The CCN family: a new stimulus package. J Endocrinol 178:169-175
18. Davies SR, Davies ML, Sanders A et al (2010) Differential expression of the CCN family member WISP-1, WISP-2 and WISP-3 in human colorectal cancer and the prognostic implications. Int J Oncol 36:1129-1136
19. Khor TO, Gul YA, Ithnin H et al (2006) A comparative study of the expression of Wnt-1, WISP-1, survivin and cyclin-D1 in colorectal carcinoma. Int J Colorectal Dis 21:291-300 (Pubitemid 43880533)
20. Banerjee S, Dhar G, Haque I et al (2008) CCN5/WISP-2 expression in breast adenocarcinoma is associated with less frequent progression of the disease and suppresses the invasive phenotypes of tumor cells. Cancer Res 68:7606-7612
21. Banerjee S, Saxena N, Sengupta K et al (2003) WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation. Neoplasia 5:63-73 (Pubitemid 36151059)
22. Nishihara K, Nagai E, Izumi Y et al (1994) Adenosquamous carcinoma of the gallbladder: a clinicopathological, immunohistochemical and flow-cytometric study of twenty cases. Jpn J Cancer Res 85:389-399 (Pubitemid 24129620)
23. Kondo M, Dono K, Sakon M et al (2002) Adenosquamous carcinoma of the gallbladder. Hepatogastroenterology 49:1230-1234
24. Oohashi Y, Shirai Y, Wakai T et al (2002) Adenosquamous carcinoma of the gallbladder warrants resection only if curative resection is feasible. Cancer 94:3000-3005 (Pubitemid 34547701)